Merck, Pfizer COVID-19 Antivirals Different From Ivermectin
Posted on AllSides October 17th, 2021
From The Left
![](https://dev.allsides.com/sites/default/files/styles/news_large_image/public/Screen%20Shot%202021-10-17%20at%205.48.29%20PM.png?itok=jVm42AhS)
Merck Sharp
DATA
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.
Throughout the COVID-19 pandemic, there has not been an easy-to-take oral pill that can prevent or treat infection with SARS-CoV-2, the coronavirus that causes COVID-19. Pharmaceutical companies, however, have been working on testing novel drug candidates, and in the last few weeks...